文献速递甲状腺疾病

分化型甲状腺癌颈部复发的手术治疗:结局与危险因素

Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors.
PubMed 文献 · J Clin Endocrinol Metab · 2017-01-01

该回顾性研究纳入161例在转诊癌症中心因分化型甲状腺癌复发/持续病灶行首次颈部再手术的患者,按2015年美国甲状腺协会指南评估再手术后反应。中位随访5年后仅53%患者无进一步治疗即达完全缓解,永久性并发症包括甲状旁腺功能减退2%、喉返神经麻痹0.6%。年龄≥45岁、侵袭性组织学及初次手术淋巴结比率≥0.6是不完全反应的独立危险因素。

要点

  • 再手术后10%患者持续结构性病灶,10%生化不完全反应,17%不确定反应,63%完全缓解。
  • 中位随访5年,仅53%患者无进一步治疗即维持完全缓解。
  • 永久性并发症:甲状旁腺功能减退2%,喉返神经麻痹0.6%,其他6%。

核心结论

  • 再手术后中位随访5年,仅53%患者无需进一步治疗即达完全缓解;应谨慎进行风险-获益分析以指导手术决策,尤其对存在不完全反应危险因素的患者。

研究设计与样本

  • 回顾性研究,连续纳入在转诊癌症中心因复发/持续分化型甲状腺癌行颈部再手术的161例患者(64%女性,中位年龄35岁,96%为乳头状分化型甲状腺癌)。
  • 再手术后反应依据2015年美国甲状腺协会指南定义。

主要发现

  • 再手术后15例(10%)持续结构性病灶,16例(10%)生化不完全反应,26例(17%)不确定反应,99例(63%)完全缓解,其中24例后续复发。
  • 中位随访5年后,仅83例(53%)无需进一步治疗即维持完全缓解。
  • 永久性并发症发生率:甲状旁腺功能减退2%,喉返神经麻痹0.6%,其他6%。
  • 年龄≥45岁、侵袭性组织学及初次手术淋巴结比率≥0.6是再手术后不完全反应的独立危险因素。
  • 男性、侵袭性组织学及再手术时≥10个转移灶是再手术后达完全缓解后二次复发的独立危险因素。

关键数值与推荐

  • 再手术后反应分类:持续结构性病灶10%,生化不完全反应10%,不确定反应17%,完全缓解63%。
  • 永久性并发症:甲状旁腺功能减退2%,喉返神经麻痹0.6%,其他6%。
  • 不完全反应独立危险因素:年龄≥45岁、侵袭性组织学、初次手术淋巴结比率≥0.6。
  • 完全缓解后二次复发独立危险因素:男性、侵袭性组织学、再手术时≥10个转移灶。

临床怎么用

  • 作者认为,应通过谨慎的风险-获益分析指导手术决策,尤其对存在不完全反应危险因素的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persistent/recurrent disease in the neck is frequent in patients with differentiated thyroid cancer (DTC). OBJECTIVE: Assess efficacy, safety, and prognostic factors of first neck reoperation in DTC. METHODS: Retrospective study of consecutive patients undergoing neck reoperation for recurrent/persistent DTC in a referral cancer center. Response after reoperation was defined according to the 2015 American Thyroid Association guidelines. FINDINGS: One hundred sixty-one DTC patients were enrolled (64% females, median age 35 years, 96% papillary DTC). Initial stage was pT3 in 43% and pT4 in 10%, pN1 in 74%. Aggressive histology was present in 25% of the patients, in both primary and persistent/recurrent tumor. Four patients had no malignancy in the reoperative specimen, and 1 patient died due to postoperative hematoma and was excluded from further analysis. Following reoperation, 15 patients (10%) had persistent structural disease, 16 (10%) had biochemical incomplete response, 26 (17%) had indeterminate response, and 99 (63%) had complete response (CR), among whom 24 relapsed later. After a median follow-up of 5 years, only 83 patients (53%) had CR without the need for further treatments. The rate of permanent complications was: hypoparathyroidism 2%, laryngeal nerve palsy 0.6%, other 6%. Age ≥45 years, aggressive histology, and lymph node ratio ≥0.6 at initial surgery were independent risk factors for incomplete response after reoperation. Male sex, aggressive histology, and ≥10 metastases at reoperation were independent risk factors of secondary relapse following CR achieved with reoperation. CONCLUSION: A careful risk-benefit analysis should guide surgical decision, particularly in patients with risk factors for incomplete response.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lamartina L, Borget I, Mirghani H, et al. Surgery for Neck Recurrence of Differentiated Thyroid Cancer: Outcomes and Risk Factors. J Clin Endocrinol Metab. 2017. PMID: 28359102. doi:10.1210/jc.2016-3284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。